Earnings
Beta Bionics Pulls Its 3D Intelligence FDA Filing And Warns Mint Could Defer Up To $8.5 Million
Third-quarter sales rose 30% to $35.5 million, but the loss widened and the 2026 revenue outlook narrowed to $124 million to $126 million.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
Earnings
Third-quarter sales rose 30% to $35.5 million, but the loss widened and the 2026 revenue outlook narrowed to $124 million to $126 million.
Earnings
The reinsurer's adjusted operating income stayed at $512.6 million, but book value per share fell 1.9% to $259.61.
SEC Filings
The faucet maker gives Moen its own president and has House of Rohl report straight to the CEO, with changes effective November 2.
SEC Filings
Lynne Fuller-Andrews leaves her executive roles as the equipment renter searches for a successor and sets her $510,000 bonus.
Deals
The secured credit line permits buybacks and acquisitions, with interest margins of 1.125% to 2.00% over term benchmarks.
Insider Trades
The $16.8 million proposed sale follows 13 sales across four related accounts that brought in $55,814,261 over three months.
Deals
The cash-and-stock deal takes UMB into Nevada and is targeted to close in the first quarter of 2027.
SEC Filings
Ayoub will lead Magic: The Gathering, D&D and Hasbro's digital games starting November 2, after a search of dozens of candidates.
Earnings
The payments network's fourth-quarter adjusted earnings reached $3.48 per share, and the board lifted the quarterly dividend to $0.780.
Deals
The Kansas City bank's efficiency ratio improved to 48.71% from 58.09% a year earlier as loan growth and lower deal costs lifted results.
Deals
Adjusted EBITDA doubled to $229 million, topping the company's own guidance, as the real estate data firm moved to buy an aerial-imagery provider.
Earnings
The pediatric orthopedics company halved its quarterly net loss to $5.9 million and guides to breakeven free cash flow for 2026.